Hear from our CEO, Adrian Treverton, about treating non-melanoma skin cancer patients safely during COVID. Patients most likely to develop basal or squamous cell carcinoma are those in the age range at greater risk of serious illness from COVID, so safe and short treatment options are important.
On the Other Side of the Machine
I have spent more than twenty years in radiation therapy, building systems, advising clinicians, and working to bring this technology to more patients. Last year, I became one of those patients myself. Diagnosed with Dupuytren’s contracture, I went through two rounds of low-dose radiation treatment at the same kind of facility I have spent my career supplying. What followed was one of the most clarifying professional experiences of my life, and a reminder that the gap between understanding a treatment and actually receiving one is wider than most people inside this industry ever appreciate.
